MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2026 International Congress

    Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses

    H. Sabet, M. Aziz, M. Zanaty (Qena, Egypt)

    Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
  • 2026 International Congress

    Cervical Dystonia: The Objective Evaluation Of Muscle Tone

    M. Falletti (Rome, Italy)

    Objective: In this study, we aimed to assess the biomechanical components underlying the postural alterations characteristic of CD. In addition, we investigated the effects of…
  • 2026 International Congress

    A Therapeutic Approach to Writer’s Cramp-Type Focal Dystonia Using Botulinum Toxin: Experience of the Neurology/Movement Disorders Department of the Hospital do Servidor Público de São Paulo

    K. Alves, T. Gonçalves, B. Dias, R. Pinto, E. Souto, D. Faria, S. Gomes (Sao Paulo, Brazil)

    Objective: To characterize the clinical and demographic profile of patients with writer’s cramp treated at the botulinum toxin outpatient clinic of the Instituto de Assistência…
  • 2026 International Congress

    Efficacy of Dysport in the treatment of late onset-lingal dystonia secondary to neuroleptics

    C. Boukadir (Benaknoun; Algiers, Algeria)

    Objective: Lingual dystonia secondary to neuroleptics is common and can persist even after a change in therapy (1), (2). The value of our work lies…
  • 2026 International Congress

    Efficacy of botulinum toxin treatment for cervical dystonia associated with Parkinson’s disease: A case series.

    S. Mian, R. Goel, E. Roddy, V. Holiday, P. Hedera (Louisville, USA)

    Objective: We present a series of patients with Parkinson’s disease (PD) who developed cervical dystonia (CD) and were managed with botulinum toxin therapy. We report…
  • 2026 International Congress

    Multimodal Imaging in Cervical Dystonia with Botulinum Toxin Treatment: A Pilot 5.0T MRI and 99mTc-MIBI SPECT/CT Study

    J. Li, L. Wang, X. Song, L. He, Y. Wang, J. Li, Y. Liu, S. Li, K. Li (Beijing, China)

    Objective: To comprehensively investigate structural, vascular, and metabolic alterations in cervical dystonia (CD) patients using ultra-high-field 5.0T magnetic resonance imaging (MRI) and 99mTc-MIBI SPECT/CT. Background:…
  • 2026 International Congress

    Effects of Botulinum Toxin Therapy on Depression, Anxiety, Pain, and Quality of Life in Patients with Dystonia

    N. Başpınar, Z. Irmak, A. Ersöz, T. Akıncı, G. Yüksel (Istanbul, Turkey)

    Objective: To evaluate changes in depression,anxiety,pain, and quality of life alongside motor improvement in patients with dystonia treated with botulinum toxin(BoNT). Background: Dystonia is a…
  • 2026 International Congress

    Beyond Symptom Relief: Physician Empathy Outperforms Clinical Severity in Predicting Quality of Life for Patients Undergoing Botulinum Toxin Therapy

    T. Kölsche, R. Jansen, M. Ringelstein, S. Meuth, J. Lee, P. Albrecht (Düsseldorf, Germany)

    Objective: To evaluate the impact of patient-perceived physician empathy on health-related quality of life (HRQoL), treatment satisfaction, and clinical outcomes in patients receiving Botulinum Neurotoxin…
  • 2026 International Congress

    Long-term utilization of onabotulinumtoxinA for the treatment of cervical dystonia

    R. Barbano, K. Dashtipour, D. Safarpour, M. Sadeghi, J. Zhao, K. Ifantides, A. Ukah, B. Jabbari (Rochester, USA)

    Objective: To characterize real-world long-term utilization of onabotulinumtoxinA (onabotA) for cervical dystonia (CD) treatment by describing demographic characteristics, clinical features, and treatment patterns of patients…
  • 2026 International Congress

    Digital acoustic biomarkers of botulinum toxin response in laryngeal dystonia: a longitudinal case report

    D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To assess whether longitudinal acoustic analysis can objectively capture treatment response to botulinum toxin type a (BoNT-A) in laryngeal dystonia. Background: Objective longitudinal markers…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley